Karol Watson

Karol E Watson

Professor, Medicine, University of California Los Angeles

Karol Watson, M.D., Ph.D., holds the John Mazziotta, M.D, Ph.D. Chair in Medicine.

Publications

  1. Buschur KL, Pottinger TD, Vogel-Claussen J, Powell CA, Aguet F, Allen NB, Ardlie K, Bluemke DA, Durda P, Hermann EA, Hoffman EA, Lima JAC, Liu Y, Malinsky D, Manichaikul A, Motahari A, Post WS, Prince MR, Rich SS, Rotter JI, Smith BM, Tracy RP, Watson K, Winther HB, Lappalainen T, Barr RG. Peripheral Blood Mononuclear Cell Gene Expression Associated with Pulmonary Microvascular Perfusion: The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease Study.. Annals of the American Thoracic Society, 2024.
  2. Lu Y, Liu Y, Dhingra LS, Caraballo C, Mahajan S, Massey D, Spatz ES, Sharma R, Rodriguez F, Watson KE, Masoudi FA, Krumholz HM. National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020.. JAMA network open, 2023.
  3. Lu Y, Liu Y, Jastreboff AM, Khera R, Ndumele CD, Rodriguez F, Watson KE, Krumholz HM. Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey.. Circulation. Cardiovascular quality and outcomes, 2023.
  4. Gadde KM, Yin X, Goldberg RB, Orchard TJ, Schlögl M, Dabelea D, Ibebuogu UN, Watson KE, Pi-Sunyer FX, Crandall JP, Temprosa M, Luchsinger JA, Diabetes Prevention Program Research Group. Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study.. Journal of the American Heart Association, 2023.
  5. Flynn S, Srikanthan P, Ravellette K, Inoue K, Watson K, Horwich T. Urinary cortisol and cardiovascular events in women vs. men: The multi-ethnic study of atherosclerosis.. American heart journal plus : cardiology research and practice, 2023.
  6. Wadhera RK, Watson KE, Carnethon MR. Advancing Cardiovascular Health Equity in the United States: Now That We Know, Where Do We Go Next?. Circulation, 2023.
  7. Vameghestahbanati M, Sack C, Wysoczanski A, Hoffman EA, Angelini E, Allen NB, Bertoni AG, Guo J, Jacobs DR, Kaufman JD, Laine A, Lin CL, Malinsky D, Michos ED, Oelsner EC, Shea SJ, Watson KE, Benedetti A, Barr RG, Smith BM. Association of dysanapsis with mortality among older adults.. The European respiratory journal, 2023.
  8. Angelini ED, Yang J, Balte PP, Hoffman EA, Manichaikul AW, Sun Y, Shen W, Austin JHM, Allen NB, Bleecker ER, Bowler R, Cho MH, Cooper CS, Couper D, Dransfield MT, Garcia CK, Han MK, Hansel NN, Hughes E, Jacobs DR, Kasela S, Kaufman JD, Kim JS, Lappalainen T, Lima J, Malinsky D, Martinez FJ, Oelsner EC, Ortega VE, Paine R, Post W, Pottinger TD, Prince MR, Rich SS, Silverman EK, Smith BM, Swift AJ, Watson KE, Woodruff PG, Laine AF, Barr RG. Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans.. Thorax, 2023.
  9. Caraballo C, Massey DS, Ndumele CD, Haywood T, Kaleem S, King T, Liu Y, Lu Y, Nunez-Smith M, Taylor HA, Watson KE, Herrin J, Yancy CW, Faust JS, Krumholz HM. Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020.. JAMA, 2023.
  10. Chehab O, Shabani M, Varadarajan V, Wu CO, Watson KE, Yeboah J, Post WS, Ambale-Venkatesh B, Bluemke DA, Michos E, Lima JAC. Endogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women.. JACC. Advances, 2023.
  11. Brandt EJ, Tobb K, Cambron JC, Ferdinand K, Douglass P, Nguyen PK, Vijayaraghavan K, Islam S, Thamman R, Rahman S, Pendyal A, Sareen N, Yong C, Palaniappan L, Ibebuogu U, Tran A, Bacong AM, Lundberg G, Watson K. Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review.. Journal of the American College of Cardiology, 2023.
  12. Velarde G, Bravo-Jaimes K, Brandt EJ, Wang D, Douglass P, Castellanos LR, Rodriguez F, Palaniappan L, Ibebuogu U, Bond R, Ferdinand K, Lundberg G, Thamman R, Vijayaraghavan K, Watson K. Locking the Revolving Door: Racial Disparities in Cardiovascular Disease.. Journal of the American Heart Association, 2023.
  13. Horwich T, Srikanthan P, Gaitonde A, Watson K, Allison M, Kronmal R. Association Between Measures of Body Composition and Coronary Calcium: Findings From the Multi-Ethnic Study of Atherosclerosis.. Journal of the American Heart Association, 2023.
  14. Shabani M, Ostovaneh MR, Ma X, Ambale Venkatesh B, Wu CO, Chahal H, Bakhshi H, McClelland RL, Liu K, Shea SJ, Burke G, Post WS, Watson KE, Folsom AR, Bluemke DA, Lima JAC. Pre-diagnostic predictors of mortality in patients with heart failure: The multi-ethnic study of atherosclerosis.. Frontiers in cardiovascular medicine, 2022.
  15. Laffin LJ, Bruemmer D, Garcia M, Brennan DM, McErlean E, Jacoby DS, Michos ED, Ridker PM, Wang TY, Watson KE, Hutchinson HG, Nissen SE. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers.. Journal of the American College of Cardiology, 2022.
  16. Inoue K, Seeman TE, Horwich T, Budoff MJ, Watson KE. Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine-Learning Approach in the MESA Study.. Circulation, 2022.
  17. Bath EP, Brown K, Harris C, Guerrero A, Kozman D, Flippen CC, Garraway I, Watson K, Holly L, Godoy SM, Norris K, Wyatt G. For us by us: Instituting mentorship models that credit minoritized medical faculty expertise and lived experience.. Frontiers in medicine, 2022.
  18. Austin TR, Jensen PN, Nasrallah IM, Habes M, Rashid T, Ware JB, Chen LY, Greenland P, Hughes TM, Post WS, Shea SJ, Watson KE, Sitlani CM, Floyd JS, Kronmal RA, Longstreth WT, Bertoni AG, Shah SJ, Bryan RN, Heckbert SR. Left Atrial Function and Arrhythmias in Relation to Small Vessel Disease on Brain MRI: The Multi-Ethnic Study of Atherosclerosis.. Journal of the American Heart Association, 2022.
  19. Smith BM, Wiemken A, Hoffman EA, Keenan BT, Allen NB, Bertoni AG, Jacobs DR, Michos ED, Watson KE, Redline S, Schwab RJ, Barr RG, Heckbert SR. Upper and Lower Airway Dysanapsis and Airflow Obstruction among Older Adults.. American journal of respiratory and critical care medicine, 2022.
  20. Elmaleh-Sachs A, Balte P, Oelsner EC, Allen NB, Baugh A, Bertoni AG, Hankinson JL, Pankow JS, Post WS, Schwartz JE, Smith BM, Watson K, Barr RG. Reply by Elmaleh-Sachs et al. to Townsend and Cowl, and to Miller et al.. American journal of respiratory and critical care medicine, 2022.
  21. Miller DV, Watson KE, Wang H, Fyfe-Kirschner B, Heide RSV. Racially related risk factors for cardiovascular disease: society for cardiovascular pathology symposium 2022.. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 2022.
  22. Hermann EA, Motahari A, Hoffman EA, Allen N, Bertoni AG, Bluemke DA, Eskandari A, Gerard SE, Guo J, Hiura GT, Kaczka DW, Michos ED, Nagpal P, Pankow J, Shah S, Smith BM, Hinckley Stukovsky K, Sun Y, Watson K, Barr RG. Pulmonary Blood Volume Among Older Adults in the Community: The MESA Lung Study.. Circulation. Cardiovascular imaging, 2022.
  23. Agarwal MA, Dhaliwal JS, Yang EH, Aksoy O, Press M, Watson K, Ziaeian B, Fonarow GC, Moriarty JM, Saggar R, Channick R. Sex Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients With Pulmonary Embolism.. Chest, 2022.
  24. Post WS, Watson KE, Hansen S, Folsom AR, Szklo M, Shea S, Barr RG, Burke G, Bertoni AG, Allen N, Pankow JS, Lima JAC, Rotter JI, Kaufman JD, Johnson WC, Kronmal RA, Diez-Roux AV, McClelland RL. Racial and Ethnic Differences in All-Cause and Cardiovascular Disease Mortality: The MESA Study.. Circulation, 2022.
  25. Carnethon MR, Rodriguez F, Watson KE. Toward a Broader Conceptualization of Disparities and Solutions.. Circulation, 2022.
  26. Oelsner EC, Krishnaswamy A, Balte PP, Allen NB, Ali T, Anugu P, Andrews HF, Arora K, Asaro A, Barr RG, Bertoni AG, Bon J, Boyle R, Chang AA, Chen G, Coady S, Cole SA, Coresh J, Cornell E, Correa A, Couper D, Cushman M, Demmer RT, Elkind MSV, Folsom AR, Fretts AM, Gabriel KP, Gallo LC, Gutierrez J, Han MLK, Henderson JM, Howard VJ, Isasi CR, Jacobs DR, Judd SE, Mukaz DK, Kanaya AM, Kandula NR, Kaplan RC, Kinney GL, Kucharska-Newton A, Lee JS, Lewis CE, Levine DA, Levitan EB, Levy BD, Make BJ, Malloy K, Manly JJ, Mendoza-Puccini C, Meyer KA, Min YN, Moll MR, Moore WC, Mauger D, Ortega VE, Palta P, Parker MM, Phipatanakul W, Post WS, Postow L, Psaty BM, Regan EA, Ring K, Roger VL, Rotter JI, Rundek T, Sacco RL, Schembri M, Schwartz DA, Seshadri S, Shikany JM, Sims M, Hinckley Stukovsky KD, Talavera GA, Tracy RP, Umans JG, Vasan RS, Watson KE, Wenzel SE, Winters K, Woodruff PG, Xanthakis V, Zhang Y, Zhang Y, C4R Investigators. Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design.. American journal of epidemiology, 2022.
  27. Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, Gadde KM, Knowler WC, Lee CG, Nathan DM, Watson K, Temprosa M, Diabetes Prevention Program Research Group*. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.. Circulation, 2022.
  28. Khan SU, Yedlapati SH, Lone AN, Khan MS, Wenger NK, Watson KE, Gulati M, Hays AG, Michos ED. A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999-2018.. European heart journal. Quality of care & clinical outcomes, 2022.
  29. Lu Y, Li SX, Liu Y, Rodriguez F, Watson KE, Dreyer RP, Khera R, Murugiah K, D'Onofrio G, Spatz ES, Nasir K, Masoudi FA, Krumholz HM. Sex-Specific Risk Factors Associated With First Acute Myocardial Infarction in Young Adults.. JAMA network open, 2022.
  30. Ebong IA, Wilson MD, Appiah D, Michos ED, Racette SB, Villablanca A, Breathett K, Lutsey PL, Wellons M, Watson KE, Chang P, Bertoni AG. Relationship Between Age at Menopause, Obesity, and Incident Heart Failure: The Atherosclerosis Risk in Communities Study.. Journal of the American Heart Association, 2022.
  31. Khan SU, Lone AN, Yedlapati SH, Dani SS, Khan MZ, Watson KE, Parwani P, Rodriguez F, Cainzos-Achirica M, Michos ED. Cardiovascular Disease Mortality Among Hispanic Versus Non-Hispanic White Adults in the United States, 1999 to 2018.. Journal of the American Heart Association, 2022.
  32. Elmaleh-Sachs A, Balte P, Oelsner EC, Allen NB, Baugh A, Bertoni AG, Hankinson JL, Pankow J, Post WS, Schwartz JE, Smith BM, Watson K, Barr RG. Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.. American journal of respiratory and critical care medicine, 2022.
  33. Hsu S, Prince DK, Williams K, Allen NB, Burke GL, Hoofnagle AN, Li X, Liu KJ, McClelland RL, Michos ED, Psaty BM, Shea SJ, Rice KM, Rotter JI, Siscovick D, Tracy RP, Watson KE, Kestenbaum BR, de Boer IH. Clinical and biomarker modifiers of vitamin D treatment response: the Multi-Ethnic Study of Atherosclerosis.. The American journal of clinical nutrition, 2022.
  34. Inoue K, Watson KE, Kondo N, Horwich T, Hsu W, Bui AAT, Duru OK. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.. JAMA network open, 2022.
  35. Kalra GL, Watson KE. Health Consequences of Segregation and Disenfranchisement.. Journal of the American Heart Association, 2022.
  36. Diaz CL, Watson KE. Racial/ethnic health disparities in cardiovascular disease during the COVID-19 pandemic: revisiting a long-lasting problem.. Cardiovascular research, 2022.
  37. Lu Y, Wang Y, Spatz ES, Onuma O, Nasir K, Rodriguez F, Watson KE, Krumholz HM. National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).. Circulation, 2021.
  38. Goldberg RB, Tripputi MT, Boyko EJ, Budoff M, Chen ZZ, Clark JM, Dabelea DM, Edelstein SL, Gerszten RE, Horton E, Mather KJ, Perreault L, Temprosa M, Wallia A, Watson K, Irfan Z. Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study.. The Journal of clinical endocrinology and metabolism, 2021.
  39. Inoue K, Horwich T, Bhatnagar R, Bhatt K, Goldwater D, Seeman T, Watson KE. Urinary Stress Hormones, Hypertension, and Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.. Hypertension (Dallas, Tex. : 1979), 2021.
  40. Mehta LS, Sharma G, Creanga AA, Hameed AB, Hollier LM, Johnson JC, Leffert L, McCullough LD, Mujahid MS, Watson K, White CJ, American Heart Association Advocacy Coordinating Committee. Call to Action: Maternal Health and Saving Mothers: A Policy Statement From the American Heart Association.. Circulation, 2021.
  41. Zhao Y, Malik S, Budoff MJ, Correa A, Ashley KE, Selvin E, Watson KE, Wong ND. Identification and Predictors for Cardiovascular Disease Risk Equivalents among Adults With Diabetes Mellitus.. Diabetes care, 2021.
  42. Pezel T, Venkatesh BA, De Vasconcellos HD, Kato Y, Shabani M, Xie E, Heckbert SR, Post WS, Shea SJ, Allen NB, Watson KE, Wu CO, Bluemke DA, Lima JAC. Left Atrioventricular Coupling Index as a Prognostic Marker of Cardiovascular Events: The MESA Study.. Hypertension (Dallas, Tex. : 1979), 2021.
  43. Albert MA, Carnethon MR, Watson KE. Disparities in Cardiovascular Medicine.. Circulation, 2021.
  44. An E, Irwin MR, Doering LV, Brecht ML, Watson KE, Corwin E, Macey PM. Mindfulness effects on lifestyle behavior and blood pressure: A randomized controlled trial.. Health science reports, 2021.
  45. An E, Irwin MR, Doering LV, Brecht ML, Watson KE, Aysola RS, Aguila AP, Harper RM, Macey PM. Which came first, obstructive sleep apnoea or hypertension? A retrospective study of electronic records over 10 years, with separation by sex.. BMJ open, 2021.
  46. Oelsner EC, Allen NB, Ali T, Anugu P, Andrews H, Asaro A, Balte PP, Barr RG, Bertoni AG, Bon J, Boyle R, Chang AA, Chen G, Cole SA, Coresh J, Cornell E, Correa A, Couper D, Cushman M, Demmer RT, Elkind MSV, Folsom AR, Fretts AM, Gabriel KP, Gallo L, Gutierrez J, Han MK, Henderson JM, Howard VJ, Isasi CR, Jacobs DR, Judd SE, Mukaz DK, Kanaya AM, Kandula NR, Kaplan R, Krishnaswamy A, Kinney GL, Kucharska-Newton A, Lee JS, Lewis CE, Levine DA, Levitan EB, Levy B, Make B, Malloy K, Manly JJ, Meyer KA, Min YI, Moll M, Moore WC, Mauger D, Ortega VE, Palta P, Parker MM, Phipatanakul W, Post W, Psaty BM, Regan EA, Ring K, Roger VL, Rotter JI, Rundek T, Sacco RL, Schembri M, Schwartz DA, Seshadri S, Shikany JM, Sims M, Hinckley Stukovsky KD, Talavera GA, Tracy RP, Umans JG, Vasan RS, Watson K, Wenzel SE, Winters K, Woodruff PG, Xanthakis V, Zhang Y, Zhang Y, C4R Investigators. Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design.. medRxiv : the preprint server for health sciences, 2021.
  47. Bahiru E, Hsiao R, Phillipson D, Watson KE. Mechanisms and Treatment of Dyslipidemia in Diabetes.. Current cardiology reports, 2021.
  48. Srikanthan P, Horwich TB, Calfon Press M, Gornbein J, Watson KE. Sex Differences in the Association of Body Composition and Cardiovascular Mortality.. Journal of the American Heart Association, 2021.
  49. Chandra NV, Hsiao R, Shapiro H, Snow S, Truong K, Beach S, Brown SA, Calfon Press MA, Gulati M, Horwich TB, Lundberg GP, Michos ED, Parwani P, Thamman R, Watson KE, Han JK. Women in Cardiology Twitter Network: An Analysis of a Global Professional Virtual Community From 2016 to 2019.. Journal of the American Heart Association, 2021.
  50. de Boer IH, Prince DK, Williams K, Allen NB, Burke GL, Hoofnagle AN, Hsu S, Li X, Liu KJ, McClelland RL, Michos ED, Psaty BM, Shea SJ, Rice KM, Rotter JI, Siscovick DS, Tracy RP, Watson KE, Kestenbaum BR. The Multi-Ethnic Study of Atherosclerosis individual response to vitamin D trial: Building a randomized clinical trial into an observational cohort study.. Contemporary clinical trials, 2021.
  51. Bond RM, Gaither K, Nasser SA, Albert MA, Ferdinand KC, Njoroge JN, Parapid B, Hayes SN, Pegus C, Sogade B, Grodzinsky A, Watson KE, McCullough CA, Ofili E, Association of Black Cardiologists. Working Agenda for Black Mothers: A Position Paper From the Association of Black Cardiologists on Solutions to Improving Black Maternal Health.. Circulation. Cardiovascular quality and outcomes, 2021.
  52. Hsu S, Hoofnagle AN, Gupta DK, Gutierrez OM, Peralta CA, Shea S, Allen NB, Burke G, Michos ED, Ix JH, Siscovick D, Psaty BM, Watson KE, Kestenbaum B, de Boer IH, Robinson-Cohen C. Race, Ancestry, and Vitamin D Metabolism: The Multi-Ethnic Study of Atherosclerosis.. The Journal of clinical endocrinology and metabolism, 2020.
  53. Hill JA, Albert MA, Carnethon MR, Watson KE. Disparities in Cardiovascular Medicine: Circulation's Response.. Circulation, 2020.
  54. Merkin SS, Karlamangla A, Roux AD, Shrager S, Watson K, Seeman T. Race/ethnicity, neighborhood socioeconomic status and cardio-metabolic risk.. SSM - population health, 2020.
  55. Smith BM, Kirby M, Hoffman EA, Kronmal RA, Aaron SD, Allen NB, Bertoni A, Coxson HO, Cooper C, Couper DJ, Criner G, Dransfield MT, Han MK, Hansel NN, Jacobs DR, Kaufman JD, Lin CL, Manichaikul A, Martinez FJ, Michos ED, Oelsner EC, Paine R, Watson KE, Benedetti A, Tan WC, Bourbeau J, Woodruff PG, Barr RG, MESA Lung, CanCOLD, and SPIROMICS Investigators. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.. JAMA, 2020.
  56. Chandra NV, Watson KE, Han JK. If You Can't See It, You Can't Be It: Mentorship for Female Internal Medicine Residents.. JACC. Case reports, 2020.
  57. Inoue K, Goldwater D, Allison M, Seeman T, Kestenbaum BR, Watson KE. Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis.. Hypertension (Dallas, Tex. : 1979), 2020.
  58. Richter SE, Miller L, Needleman J, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA. Risk factors for development of aminoglycoside resistance among gram-negative rods.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019.
  59. Lim DJ, Ambale-Ventakesh B, Ostovaneh MR, Zghaib T, Ashikaga H, Wu C, Watson KE, Hughes T, Shea S, Heckbert SR, Bluemke DA, Post WS, Lima JAC. Change in left atrial function predicts incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.. European heart journal. Cardiovascular Imaging, 2019.
  60. Rahman O, Markl M, Balte P, Berhane H, Blanken C, Suwa K, Dashnaw S, Wieben O, Bluemke DA, Prince MR, Lima J, Michos E, Ambale-Venkatesh B, Hoffman EA, Gomes AS, Watson K, Sun Y, Carr J, Barr RG. Reproducibility and Changes in Vena Caval Blood Flow by Using 4D Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Substudy.. Radiology, 2019.
  61. Kim C, Ricardo AC, Boyko EJ, Christophi CA, Temprosa M, Watson KE, Pi-Sunyer X, Kalyani RR, Diabetes Prevention Program Research Group. Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study.. The Journal of clinical endocrinology and metabolism, 2019.
  62. Han JK, Yano EM, Watson KE, Ebrahimi R. Cardiovascular Care in Women Veterans.. Circulation, 2019.
  63. Richter SE, Miller L, Needleman J, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA. Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods.. Open forum infectious diseases, 2019.
  64. Caufield JH, Zhou Y, Garlid AO, Setty SP, Liem DA, Cao Q, Lee JM, Murali S, Spendlove S, Wang W, Zhang L, Sun Y, Bui A, Hermjakob H, Watson KE, Ping P. A reference set of curated biomedical data and metadata from clinical case reports.. Scientific data, 2018.
  65. Caufield JH, Liem DA, Garlid AO, Zhou Y, Watson K, Bui AAT, Wang W, Ping P. A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts.. Journal of visualized experiments : JoVE, 2018.
  66. Goldwater D, Karlamangla A, Merkin SS, Watson K, Seeman T. Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population: Multi-Ethnic Study of Atherosclerosis.. Annals of epidemiology, 2018.
  67. Richter SE, Miller L, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.. Journal of clinical microbiology, 2018.
  68. Writing Committee Members, Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, ACC Task Force on Expert Consensus Decision Pathways, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018.
  69. Writing Committee Members, Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, ACC Task Force On Expert Consensus Decision Pathways, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018.
  70. Writing Committee Members, Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, ACC Task Force On Expert Consensus Decision Pathways, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018.
  71. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary Calcium Score and Cardiovascular Risk.. Journal of the American College of Cardiology, 2018.
  72. Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).. European heart journal, 2018.
  73. Oelsner EC, Smith BM, Hoffman EA, Kalhan R, Donohue KM, Kaufman JD, Nguyen JN, Manichaikul AW, Rotter JI, Michos ED, Jacobs DR, Burke GL, Folsom AR, Schwartz JE, Watson K, Barr RG. Prognostic Significance of Large Airway Dimensions on Computed Tomography in the General Population. The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.. Annals of the American Thoracic Society, 2018.
  74. Volgman AS, Palaniappan LS, Aggarwal NT, Gupta M, Khandelwal A, Krishnan AV, Lichtman JH, Mehta LS, Patel HN, Shah KS, Shah SH, Watson KE, American Heart Association Council on Epidemiology and Prevention; Cardiovascular Disease and Stroke. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.. Circulation, 2018.
  75. Seeman T, Thomas D, Merkin SS, Moore K, Watson K, Karlamangla A. The Great Recession worsened blood pressure and blood glucose levels in American adults.. Proceedings of the National Academy of Sciences of the United States of America, 2018.
  76. Hazlehurst MF, Spalt EW, Nicholas TP, Curl CL, Davey ME, Burke GL, Watson KE, Vedal S, Kaufman JD. Contribution of the in-vehicle microenvironment to individual ambient-source nitrogen dioxide exposure: the Multi-Ethnic Study of Atherosclerosis and Air Pollution.. Journal of exposure science & environmental epidemiology, 2018.
  77. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS, American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the . Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.. Circulation, 2018.
  78. Smith BM, Traboulsi H, Austin JHM, Manichaikul A, Hoffman EA, Bleecker ER, Cardoso WV, Cooper C, Couper DJ, Dashnaw SM, Guo J, Han MK, Hansel NN, Hughes EW, Jacobs DR, Kanner RE, Kaufman JD, Kleerup E, Lin CL, Liu K, Lo Cascio CM, Martinez FJ, Nguyen JN, Prince MR, Rennard S, Rich SS, Simon L, Sun Y, Watson KE, Woodruff PG, Baglole CJ, Barr RG, MESA Lung and SPIROMICS investigators. Human airway branch variation and chronic obstructive pulmonary disease.. Proceedings of the National Academy of Sciences of the United States of America, 2018.
  79. Robinson JG, Watson KE. Identifying Patients for Nonstatin Therapy.. Reviews in cardiovascular medicine, 2018.
  80. Brown AS, Watson KE. Statin Intolerance.. Reviews in cardiovascular medicine, 2018.
  81. Aaron CP, Schwartz JE, Hoffman EA, Angelini E, Austin JHM, Cushman M, Jacobs DR, Kaufman JD, Laine A, Smith LJ, Yang J, Watson KE, Tracy RP, Barr RG. A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study.. Chest, 2017.
  82. Watson KE, Fonarow GC. Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein ≥190 mg/dL.. Circulation, 2017.
  83. Oelsner EC, Smith BM, Hoffman EA, Folsom AR, Kawut SM, Kaufman JD, Manichaikul A, Lederer DJ, Schwartz JE, Watson KE, Enright PL, Austin JHM, Lima JAC, Shea SJ, Barr RG. Associations between emphysema-like lung on CT and incident airflow limitation: a general population-based cohort study.. Thorax, 2017.
  84. Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, Ratner R, Barrett-Connor E, Temprosa M. Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.. BMJ open diabetes research & care, 2017.
  85. Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.. Atherosclerosis, 2017.
  86. Luchsinger JA, Ma Y, Christophi CA, Florez H, Golden SH, Hazuda H, Crandall J, Venditti E, Watson K, Jeffries S, Manly JJ, Pi-Sunyer FX, Diabetes Prevention Program Research Group. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study.. Diabetes care, 2017.
  87. Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff M, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M, Diabetes Prevention Program Research Group. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.. Circulation, 2017.
  88. Parikh MA, Aaron CP, Hoffman EA, Schwartz JE, Madrigano J, Austin JHM, Kalhan R, Lovasi G, Watson K, Stukovsky KH, Barr RG. Angiotensin-Converting Inhibitors and Angiotensin II Receptor Blockers and Longitudinal Change in Percent Emphysema on Computed Tomography. The Multi-Ethnic Study of Atherosclerosis Lung Study.. Annals of the American Thoracic Society, 2017.
  89. Aaron CP, Hoffman EA, Lima JAC, Kawut SM, Bertoni AG, Vogel-Claussen J, Habibi M, Hueper K, Jacobs DR, Kalhan R, Michos ED, Post WS, Prince MR, Smith BM, Ambale-Venkatesh B, Liu CY, Zemrak F, Watson KE, Budoff M, Bluemke DA, Barr RG. Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study.. PloS one, 2017.
  90. Ping P, Watson K, Han J, Bui A. Individualized Knowledge Graph: A Viable Informatics Path to Precision Medicine.. Circulation research, 2017.
  91. Zipursky RT, Press MC, Srikanthan P, Gornbein J, McClelland R, Watson K, Horwich TB. Relation of Stress Hormones (Urinary Catecholamines/Cortisol) to Coronary Artery Calcium in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis [MESA]).. The American journal of cardiology, 2017.
  92. Wiesner P, Watson KE. Triglycerides: A reappraisal.. Trends in cardiovascular medicine, 2017.
  93. Doyle MF, Tracy RP, Parikh MA, Hoffman EA, Shimbo D, Austin JH, Smith BM, Hueper K, Vogel-Claussen J, Lima J, Gomes A, Watson K, Kawut S, Barr RG. Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema.. PloS one, 2017.
  94. Mujahid MS, Moore LV, Petito LC, Kershaw KN, Watson K, Diez Roux AV. Neighborhoods and racial/ethnic differences in ideal cardiovascular health (the Multi-Ethnic Study of Atherosclerosis).. Health & place, 2017.
  95. Podolanczuk AJ, Raghu G, Tsai MY, Kawut SM, Peterson E, Sonti R, Rabinowitz D, Johnson C, Barr RG, Hinckley Stukovsky K, Hoffman EA, Carr JJ, Ahmed FS, Jacobs DR, Watson K, Shea SJ, Lederer DJ. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.. Thorax, 2017.
  96. Chester RC, Gornbein JA, Hundley WG, Srikanthan P, Watson KE, Horwich T. Reflection Magnitude, a Measure of Arterial Stiffness, Predicts Incident Heart Failure in Men But Not Women: Multi-Ethnic Study of Atherosclerosis (MESA).. Journal of cardiac failure, 2017.
  97. Armstrong HF, Lovasi GS, Soliman EZ, Heckbert SR, Psaty BM, Austin JH, Krishnan JA, Hoffman EA, Johnson C, Budoff MJ, Watson KE, Barr RG. Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.. Respiratory medicine, 2016.
  98. Varga TV, Winters AH, Jablonski KA, Horton ES, Khare-Ranade P, Knowler WC, Marcovina SM, Renström F, Watson KE, Goldberg R, Florez JC, Pollin TI, Franks PW. Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.. Circulation. Cardiovascular genetics, 2016.
  99. Watson KE, Sallam T. MY APPROACH to the Patient With Memory Loss Who Needs a Statin.. Trends in cardiovascular medicine, 2016.
  100. Bertoni AG, Kramer H, Watson K, Post WS. Diabetes and Clinical and Subclinical CVD.. Global heart, 2016.
  101. Lau E, Watson KE, Ping P. Connecting the Dots: From Big Data to Healthy Heart.. Circulation, 2016.
  102. Ebong IA, Watson KE, Hairston KG, Carnethon MR, Ouyang P, Szklo M, Bertoni AG. Body fat distribution, menopausal hormone therapy and incident type 2 diabetes in postmenopausal women of the MESA study.. Maturitas, 2016.
  103. Kaufman JD, Adar SD, Barr RG, Budoff M, Burke GL, Curl CL, Daviglus ML, Diez Roux AV, Gassett AJ, Jacobs DR, Kronmal R, Larson TV, Navas-Acien A, Olives C, Sampson PD, Sheppard L, Siscovick DS, Stein JH, Szpiro AA, Watson KE. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study.. Lancet (London, England), 2016.
  104. Mukku RB, Fonarow GC, Watson KE, Ajijola OA, Depasquale EC, Nsair A, Baas AS, Deng MC, Yang EH. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.. Journal of cardiac failure, 2016.
  105. Watson KE, Wiesner P. Slippery Slope of Triglycerides: They Are Associated With Risk, But in the Statin Era, Does Targeting Them Confer Benefit?. Circulation. Cardiovascular quality and outcomes, 2016.
  106. Wickramasinghe CD, Nguyen KL, Watson KE, Vorobiof G, Yang EH. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.. Future oncology (London, England), 2016.
  107. Ziaeian B, Dinkler J, Guo Y, Watson K. The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with Diabetes.. Current diabetes reports, 2016.
  108. Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK, American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the . Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association.. Circulation, 2016.
  109. Effoe VS, Chen H, Moran A, Bertoni AG, Bluemke DA, Seeman T, Darwin C, Watson KE, Rodriguez CJ. Acculturation is associated with left ventricular mass in a multiethnic sample: the Multi-Ethnic Study of Atherosclerosis.. BMC cardiovascular disorders, 2015.
  110. McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, Bild DE, Shea S, Liu K, Watson KE, Folsom AR, Khera A, Ayers C, Mahabadi AA, Lehmann N, Jöckel KH, Moebus S, Carr JJ, Erbel R, Burke GL. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study).. Journal of the American College of Cardiology, 2015.
  111. Hueper K, Vogel-Claussen J, Parikh MA, Austin JH, Bluemke DA, Carr J, Choi J, Goldstein TA, Gomes AS, Hoffman EA, Kawut SM, Lima J, Michos ED, Post WS, Po MJ, Prince MR, Liu K, Rabinowitz D, Skrok J, Smith BM, Watson K, Yin Y, Zambeli-Ljepovic AM, Barr RG. Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.. American journal of respiratory and critical care medicine, 2015.
  112. Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sánchez BN, Moore K, Adar SD, Horwich TB, Watson KE, Diez Roux AV. Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).. JAMA internal medicine, 2015.
  113. Stone NJ, Merz CN, Watson KE, Smith SC. Getting guidelines correct: their evidence-based recommendations for use of nonstatins added to statins and the need for follow-up lipid testing.. Journal of the American College of Cardiology, 2015.
  114. Ebong IA, Watson KE, Goff DC, Bluemke DA, Srikanthan P, Horwich T, Bertoni AG. Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis.. Menopause (New York, N.Y.), 2015.
  115. Dean DA, Wang R, Jacobs DR, Duprez D, Punjabi NM, Zee PC, Shea S, Watson K, Redline S. A systematic assessment of the association of polysomnographic indices with blood pressure: the Multi-Ethnic Study of Atherosclerosis (MESA).. Sleep, 2015.
  116. Scruggs SB, Watson K, Su AI, Hermjakob H, Yates JR, Lindsey ML, Ping P. Harnessing the heart of big data.. Circulation research, 2015.
  117. Chahal H, Heckbert SR, Barr RG, Bluemke DA, Jain A, Habibi M, Alonso A, Kronmal R, Jacobs DR, Lima JA, Watson KE, Liu K, Smith LJ, Greenland P. Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).. The American journal of cardiology, 2015.
  118. Mitchell A, Misialek JR, Folsom AR, Duprez D, Alonso A, Jerosch-Herold M, Sanchez OA, Watson KE, Sallam T, Konety SH. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).. The American journal of cardiology, 2015.
  119. Sharma RK, Donekal S, Rosen BD, Tattersall MC, Volpe GJ, Ambale-Venkatesh B, Nasir K, Wu CO, Polak JF, Korcarz CE, Stein JH, Carr J, Watson KE, Bluemke DA, Lima JA. Association of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of Atherosclerosis.. Atherosclerosis, 2015.
  120. Ziaeian B, Dinkler J, Watson K. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.. Reviews in cardiovascular medicine, 2015.
  121. Yang EH, Watson KE, Herrmann J. Should vascular effects of newer treatments be addressed more completely?. Future oncology (London, England), 2015.
  122. Chahal H, Bluemke DA, Wu CO, McClelland R, Liu K, Shea SJ, Burke G, Balfour P, Herrington D, Shi P, Post W, Olson J, Watson KE, Folsom AR, Lima JA. Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis.. Heart (British Cardiac Society), 2014.
  123. Dinkler J, Watson K. Practical Implementation of the 2013 AHA/ACC Blood Cholesterol Guidelines.. Current treatment options in cardiovascular medicine, 2014.
  124. Soverow J, Watson K. Is there sufficient enhancement of the reduction in CVD rates after a decade of statin therapy to justify continuation?. Current atherosclerosis reports, 2014.
  125. Delahanty LM, Pan Q, Jablonski KA, Aroda VR, Watson KE, Bray GA, Kahn SE, Florez JC, Perreault L, Franks PW, Diabetes Prevention Program Research Group. Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program.. Diabetes care, 2014.
  126. Ebong IA, Watson KE, Goff DC, Bluemke DA, Srikanthan P, Horwich T, Bertoni AG. Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis.. Menopause (New York, N.Y.), 2014.
  127. Goldberg RB, Temprosa MG, Mather KJ, Orchard TJ, Kitabchi AE, Watson KE, Diabetes Prevention Program Research Group. Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.. Diabetes care, 2014.
  128. Criqui MH, Denenberg JO, McClelland RL, Allison MA, Ix JH, Guerci A, Cohoon KP, Srikanthan P, Watson KE, Wong ND. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis.. Arteriosclerosis, thrombosis, and vascular biology, 2014.
  129. Rifkin DE, Khaki AR, Jenny NS, McClelland RL, Budoff M, Watson K, Ix JH, Allison MA. Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis.. American journal of hypertension, 2014.
  130. McMahon M, Skaggs BJ, Grossman JM, Sahakian L, Fitzgerald J, Wong WK, Lourenco EV, Ragavendra N, Charles-Schoeman C, Gorn A, Karpouzas GA, Taylor MB, Watson KE, Weisman MH, Wallace DJ, Hahn BH. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.. Arthritis & rheumatology (Hoboken, N.J.), 2014.
  131. Watson KE, Stocker EH, Jacoby DS, McCullough PA. Advanced lipid testing: when, why, and in whom?. Reviews in cardiovascular medicine, 2014.
  132. O'Brien EC, Roe MT, Fraulo ES, Peterson ED, Ballantyne CM, Genest J, Gidding SS, Hammond E, Hemphill LC, Hudgins LC, Kindt I, Moriarty PM, Ross J, Underberg JA, Watson K, Pickhardt D, Rader DJ, Wilemon K, Knowles JW. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.. American heart journal, 2013.
  133. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.. Circulation, 2013.
  134. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.. Journal of the American College of Cardiology, 2013.
  135. Sallam T, Watson KE. Predictors of cardiovascular risk in women.. Women's health (London, England), 2013.
  136. Burkart KM, Manichaikul A, Wilk JB, Ahmed FS, Burke GL, Enright P, Hansel NN, Haynes D, Heckbert SR, Hoffman EA, Kaufman JD, Kurai J, Loehr L, London SJ, Meng Y, O'Connor GT, Oelsner E, Petrini M, Pottinger TD, Powell CA, Redline S, Rotter JI, Smith LJ, Soler Artigas M, Tobin MD, Tsai MY, Watson K, White W, Young TR, Rich SS, Barr RG. APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.. The European respiratory journal, 2013.
  137. Soliman EZ, Alonso A, Misialek JR, Jain A, Watson KE, Lloyd-Jones DM, Lima J, Shea S, Burke GL, Heckbert SR. Reference ranges of PR duration and P-wave indices in individuals free of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA).. Journal of electrocardiology, 2013.
  138. Adar SD, Sheppard L, Vedal S, Polak JF, Sampson PD, Diez Roux AV, Budoff M, Jacobs DR, Barr RG, Watson K, Kaufman JD. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution.. PLoS medicine, 2013.
  139. Powell R, Davidson D, Divers J, Manichaikul A, Carr JJ, Detrano R, Hoffman EA, Jiang R, Kronmal RA, Liu K, Punjabi NM, Shahar E, Watson KE, Rotter JI, Taylor KD, Rich SS, Barr RG. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study.. Thorax, 2013.
  140. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.. Lancet (London, England), 2012.
  141. Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW, Diabetes Prevention Program Research Group. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.. Diabetes care, 2011.
  142. Van Hee VC, Szpiro AA, Prineas R, Neyer J, Watson K, Siscovick D, Kyun Park S, Kaufman JD. Association of long-term air pollution with ventricular conduction and repolarization abnormalities.. Epidemiology (Cambridge, Mass.), 2011.
  143. Kim C, Diez-Roux AV, Nettleton JA, Polak JF, Post WS, Siscovick DS, Watson KE, Vahratian AM. Sex differences in subclinical atherosclerosis by race/ethnicity in the multi-ethnic study of atherosclerosis.. American journal of epidemiology, 2011.
  144. Huang CC, Liu K, Pope RM, Du P, Lin S, Rajamannan NM, Huang QQ, Jafari N, Burke GL, Post W, Watson KE, Johnson C, Daviglus ML, Lloyd-Jones DM. Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis.. PloS one, 2011.
  145. Mitchell JE, Ferdinand KC, Watson KE, Wenger NK, Watkins LO, Flack JM, Gavin JR, Reed JW, Saunders E, Wright JT. Treatment of heart failure in African Americans--a call to action.. Journal of the National Medical Association, 2011.
  146. Sanchez DR, Diez Roux AV, Michos ED, Blumenthal RS, Schreiner PJ, Burke GL, Watson K. Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis.. The American journal of cardiology, 2011.
  147. Jain A, McClelland RL, Polak JF, Shea S, Burke GL, Bild DE, Watson KE, Budoff MJ, Liu K, Post WS, Folsom AR, Lima JA, Bluemke DA. Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the multi-ethnic study of atherosclerosis (MESA).. Circulation. Cardiovascular imaging, 2010.
  148. Mair C, Diez Roux AV, Osypuk TL, Rapp SR, Seeman T, Watson KE. Is neighborhood racial/ethnic composition associated with depressive symptoms? The multi-ethnic study of atherosclerosis.. Social science & medicine (1982), 2010.
  149. Hajat A, Diez-Roux A, Franklin TG, Seeman T, Shrager S, Ranjit N, Castro C, Watson K, Sanchez B, Kirschbaum C. Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis.. Psychoneuroendocrinology, 2010.
  150. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airflow obstruction, and impaired left ventricular filling.. The New England journal of medicine, 2010.
  151. Watson KE. Pitavastatin: the newest HMG-CoA reductase inhibitor.. Reviews in cardiovascular medicine, 2010.
  152. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC, Wilson PW, Watson KE, Steg PG, REACH Registry Investigators. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.. American heart journal, 2009.
  153. Kershaw KN, Diez Roux AV, Carnethon M, Darwin C, Goff DC, Post W, Schreiner PJ, Watson K. Geographic variation in hypertension prevalence among blacks and whites: the multi-ethnic study of atherosclerosis.. American journal of hypertension, 2009.
  154. Ferdinand KC, Flack JM, Saunders E, Victor R, Watson K, Kursun A, Jamieson MJ, Shi H. Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.. Journal of clinical hypertension (Greenwich, Conn.), 2009.
  155. Gallo LC, de Los Monteros KE, Allison M, Diez Roux A, Polak JF, Watson KE, Morales LS. Do socioeconomic gradients in subclinical atherosclerosis vary according to acculturation level? Analyses of Mexican-Americans in the multi-ethnic study of atherosclerosis.. Psychosomatic medicine, 2009.
  156. McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N, Charles-Schoeman C, Watson K, Wong WK, Volkmann E, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH. Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.. Arthritis and rheumatism, 2009.
  157. Ranjit N, Diez-Roux AV, Sanchez B, Seeman T, Shea S, Shrager S, Watson K. Association of salivary cortisol circadian pattern with cynical hostility: multi-ethnic study of atherosclerosis.. Psychosomatic medicine, 2009.
  158. Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M. Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.. Journal of the American Society of Hypertension : JASH, 2009.
  159. Watson KE. The JUPITER trial: How will it change clinical practice?. Reviews in cardiovascular medicine, 2009.
  160. Cziraky MJ, Watson KE, Talbert RL. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.. Journal of managed care pharmacy : JMCP, 2008.
  161. Friedman AN, Friedman A, Marrero D, Ma Y, Ackermann R, Narayan KM, Barrett-Connor E, Watson K, Knowler WC, Horton ES, Diabetes Prevention Program Research Group. Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals.. Diabetes care, 2008.
  162. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, Budoff MJ, Liu K, Shea S, Szklo M, Tracy RP, Watson KE, Burke GL. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).. Archives of internal medicine, 2008.
  163. Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, Chung H, Carnethon MR. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis.. Archives of internal medicine, 2008.
  164. Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease observations from the ACCORD study: now what can a clinician possibly think?. Diabetes, 2008.
  165. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups.. The New England journal of medicine, 2008.
  166. Watson KE. What is the evidence in favor of low-dose statin therapy in 2008?. Current atherosclerosis reports, 2008.
  167. Watson KE. Cardiovascular risk reduction among African Americans: a call to action.. Journal of the National Medical Association, 2008.
  168. Flack JM, Victor R, Watson K, Ferdinand KC, Saunders E, Tarasenko L, Jamieson MJ, Shi H, Bruschi P. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.. Mayo Clinic proceedings, 2008.
  169. Watson K, Fung CH, Budoff M. Quality indicators for the care of ischemic heart disease in vulnerable elders.. Journal of the American Geriatrics Society, 2007.
  170. Gorkin JU, Watson K, Knopp RH. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.. The Journal of family practice, 2007.
  171. Watson K. Managing cardiometabolic risk: an evolving approach to patient care.. Critical pathways in cardiology, 2007.
  172. Watson KE, Ansell BJ, Watson AD, Fonarow GC. HDL function as a target of lipid-modifying therapy.. Reviews in cardiovascular medicine, 2007.
  173. Fonarow GC, Watson KE. New insights into understanding cardiometabolic risk. Introduction.. Reviews in cardiovascular medicine, 2007.
  174. Watson KE. Novel therapies for cardiometabolic risk reduction and implications for clinical practice.. Reviews in cardiovascular medicine, 2007.
  175. Watson KE. Pathogenesis of CHD: the role of elevated triglycerides.. Journal of the American Academy of Nurse Practitioners, 2007.
  176. Watson K. Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.. Current cardiology reports, 2006.
  177. Polk DM, Watson K. Hospital discharge treatments after an acute event: evidence for a systems approach to prevention.. Coronary artery disease, 2006.
  178. Hall WD, Watkins LO, Wright JT, Wenger NK, Kumanyika SK, Gavin JR, Ferdinand KC, Watson K, Clark LT, Flack JM, Reed JW, Horton EW, Saunders E, African-American Lipid and Cardiovascular Council. The metabolic syndrome: recognition and management.. Disease management : DM, 2006.
  179. Watson KE. Air pollution and heart disease.. Reviews in cardiovascular medicine, 2006.
  180. Watson KE. Lowering levels of lipids and homocysteine.. Reviews in cardiovascular medicine, 2006.
  181. Fonarow GC, Watson KE. Treating to low-density lipoprotein goal: a tool for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis or similar risk.. Critical pathways in cardiology, 2005.
  182. Ferdinand KC, Clark LT, Watson KE, Neal RC, Brown CD, Kong BW, Barnes BO, Cox WR, Zieve FJ, Isaacsohn J, Ycas J, Sager PT, Gold A, ARIES Study Group. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial.. The American journal of cardiology, 2005.
  183. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. High-density lipoprotein function recent advances.. Journal of the American College of Cardiology, 2005.
  184. Watson K. Guidelines for prevention of CVD in women.. The Journal of family practice, 2005.
  185. Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.. Circulation, 2005.
  186. Watson KE. Novel serum markers for risk prediction in acute coronary syndromes.. Reviews in cardiovascular medicine, 2005.
  187. Watson KE, Fonarow GC. The past, present, and future of statin therapy.. Reviews in cardiovascular medicine, 2005.
  188. Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. Anti-inflammatory properties of HDL.. Reviews in endocrine & metabolic disorders, 2004.
  189. Fonarow GC, Watson KE. High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events.. American heart journal, 2004.
  190. Watson KE, Fonarow GC. Cardiovascular disease in African Americans. Closing the knowledge, treatment, and outcome gap.. Reviews in cardiovascular medicine, 2004.
  191. Watson KE. Cardiovascular disease in African Americans. Introduction.. Reviews in cardiovascular medicine, 2004.
  192. Krantz MJ, Leeman-Castillo BA, Watson KE, Mehler PS. Coronary heart disease care in older women: optimizing diagnostic and therapeutic decisions.. Journal of the American Medical Women's Association (1972), 2004.
  193. Watson KE, Topol EJ. Pathobiology of atherosclerosis: are there racial and ethnic differences?. Reviews in cardiovascular medicine, 2004.
  194. Watson KE. The relationship between inflammation and atherosclerotic events.. Reviews in cardiovascular medicine, 2004.
  195. Watson KE, Peters Harmel AL, Matson G. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.. Journal of cardiovascular pharmacology and therapeutics, 2003.
  196. Watson KE. Plasma lipoprotein concentrations in ethnic populations.. Current cardiology reports, 2003.
  197. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL. Multilineage potential of cells from the artery wall.. Circulation, 2003.
  198. Fonarow GC, Watson KE. Effective strategies for long-term statin use.. The American journal of cardiology, 2003.
  199. Fonarow GC, Gawlinski A, Watson K. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.. Critical pathways in cardiology, 2003.
  200. Hall WD, Clark LT, Wenger NK, Wright JT, Kumanyika SK, Watson K, Horton EW, Flack JM, Ferdinand KC, Gavin JR, Reed JW, Saunders E, O'Neal W. For the patient. What is the Metabolic Syndrome and why is it important?. Ethnicity & disease, 2003.
  201. Watson KE, Fonarow GC. Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice.. Clinical cornerstone, 2003.
  202. Watson KE, Horowitz BN, Matson G. Lipid abnormalities in insulin resistant states.. Reviews in cardiovascular medicine, 2003.
  203. Hall WD, Clark LT, Wenger NK, Wright JT, Kumanyika SK, Watson K, Horton EW, Flack JM, Ferdinand KC, Gavin JR, Reed JW, Saunders E, O'Neal W, African-American Lipid and Cardiovascular Council. The Metabolic Syndrome in African Americans: a review.. Ethnicity & disease, 2003.
  204. Watson K, Jamerson K. Therapeutic lifestyle changes for hypertension and cardiovascular risk reduction.. Journal of clinical hypertension (Greenwich, Conn.), 2003.
  205. Ansell BJ, Watson KE, Weiss RE, Fonarow GC. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation.. Heart disease (Hagerstown, Md.), 2003.
  206. Watson K. Lipid lowering in high-risk populations: how low should we go?. Ethnicity & disease, 2001.